Guam

Reimbursed Care Access

Guam administers controlled‑substance scheduling through its local Uniform Controlled Substances Act but defers to federal scheduling by default; FDA‑approved agents and standard medical uses (e.g., esketamine/Spravato, ketamine as an FDA‑authorized anesthetic) can be provided in licensed clinical settings, while classic serotonergic psychedelics (psilocybin, MDMA, DMT, 5‑MeO‑DMT, ibogaine, ayahuasca, mescaline, 2C‑X) remain prohibited outside of authorized clinical research. Reimbursement is highly dependent on the drug’s U.S. federal/FDA status and on Guam’s payer policies (Medicaid/Medicare/private insurers), producing a patchwork in practical access and coverage.